カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のパロノセトロン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Palonosetron Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19510）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19510
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のパロノセトロン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

パロノセトロン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のパロノセトロンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

パロノセトロン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・注射0.25mg/5mL、注射20mcg/kg (最大1.5mg)

用途別セグメントは次のように区分されます。
・大人、子供

世界のパロノセトロン市場の主要な市場プレーヤーは以下のとおりです。
・Helsinn Therapeutics、Teva、Dr. Reddys Laboratories、Cipla、Pfizer、Sandoz、Aurobindo、Sagent Pharmaceuticals、Fresenius Kabi、Qilu Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Sichuan Hairong Pharmaceutical、Exela Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、パロノセトロン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なパロノセトロンメーカーの企業概要、2019年～2022年までのパロノセトロンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なパロノセトロンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別パロノセトロンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのパロノセトロンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのパロノセトロン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびパロノセトロンの産業チェーンを掲載しています。
・第13、14、15章では、パロノセトロンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- パロノセトロンの概要
- 種類別分析（2017年vs2021年vs2028年）：注射0.25mg/5mL、注射20mcg/kg (最大1.5mg)
- 用途別分析（2017年vs2021年vs2028年）：大人、子供
- 世界のパロノセトロン市場規模・予測
- 世界のパロノセトロン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Helsinn Therapeutics、Teva、Dr. Reddys Laboratories、Cipla、Pfizer、Sandoz、Aurobindo、Sagent Pharmaceuticals、Fresenius Kabi、Qilu Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Sichuan Hairong Pharmaceutical、Exela Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：注射0.25mg/5mL、注射20mcg/kg (最大1.5mg)
・用途別分析2017年-2028年：大人、子供
・パロノセトロンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・パロノセトロンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・パロノセトロンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・パロノセトロンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・パロノセトロンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Palonosetron market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Palonosetron market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults accounting for % of the Palonosetron global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injection 0.25 mg/5 mL segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Palonosetron include Helsinn Therapeutics, Teva, Dr. Reddys Laboratories, Cipla, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Palonosetron market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection 0.25 mg/5 mL
Injection 20 mcg/kg (max 1.5 mg)
Market segment by Application can be divided into
Adults
Children
The key market players for global Palonosetron market are listed below:
Helsinn Therapeutics
Teva
Dr. Reddys Laboratories
Cipla
Pfizer
Sandoz
Aurobindo
Sagent Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Sichuan Hairong Pharmaceutical
Exela Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Palonosetron product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Palonosetron, with price, sales, revenue and global market share of Palonosetron from 2019 to 2022.
Chapter 3, the Palonosetron competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Palonosetron breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Palonosetron market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Palonosetron.
Chapter 13, 14, and 15, to describe Palonosetron sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Palonosetron Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Palonosetron Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Injection 0.25 mg/5 mL
1.2.3 Injection 20 mcg/kg (max 1.5 mg)
1.3 Market Analysis by Application
1.3.1 Overview: Global Palonosetron Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.4 Global Palonosetron Market Size & Forecast
1.4.1 Global Palonosetron Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Palonosetron Sales in Volume (2017-2028)
1.4.3 Global Palonosetron Price (2017-2028)
1.5 Global Palonosetron Production Capacity Analysis
1.5.1 Global Palonosetron Total Production Capacity (2017-2028)
1.5.2 Global Palonosetron Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Palonosetron Market Drivers
1.6.2 Palonosetron Market Restraints
1.6.3 Palonosetron Trends Analysis
2 Manufacturers Profiles
2.1 Helsinn Therapeutics
2.1.1 Helsinn Therapeutics Details
2.1.2 Helsinn Therapeutics Major Business
2.1.3 Helsinn Therapeutics Palonosetron Product and Services
2.1.4 Helsinn Therapeutics Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Palonosetron Product and Services
2.2.4 Teva Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dr. Reddys Laboratories
2.3.1 Dr. Reddys Laboratories Details
2.3.2 Dr. Reddys Laboratories Major Business
2.3.3 Dr. Reddys Laboratories Palonosetron Product and Services
2.3.4 Dr. Reddys Laboratories Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Palonosetron Product and Services
2.4.4 Cipla Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Palonosetron Product and Services
2.5.4 Pfizer Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sandoz
2.6.1 Sandoz Details
2.6.2 Sandoz Major Business
2.6.3 Sandoz Palonosetron Product and Services
2.6.4 Sandoz Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Aurobindo
2.7.1 Aurobindo Details
2.7.2 Aurobindo Major Business
2.7.3 Aurobindo Palonosetron Product and Services
2.7.4 Aurobindo Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sagent Pharmaceuticals
2.8.1 Sagent Pharmaceuticals Details
2.8.2 Sagent Pharmaceuticals Major Business
2.8.3 Sagent Pharmaceuticals Palonosetron Product and Services
2.8.4 Sagent Pharmaceuticals Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fresenius Kabi
2.9.1 Fresenius Kabi Details
2.9.2 Fresenius Kabi Major Business
2.9.3 Fresenius Kabi Palonosetron Product and Services
2.9.4 Fresenius Kabi Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Qilu Pharmaceutical
2.10.1 Qilu Pharmaceutical Details
2.10.2 Qilu Pharmaceutical Major Business
2.10.3 Qilu Pharmaceutical Palonosetron Product and Services
2.10.4 Qilu Pharmaceutical Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Jiangsu Aosaikang Pharmaceutical
2.11.1 Jiangsu Aosaikang Pharmaceutical Details
2.11.2 Jiangsu Aosaikang Pharmaceutical Major Business
2.11.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Product and Services
2.11.4 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sichuan Hairong Pharmaceutical
2.12.1 Sichuan Hairong Pharmaceutical Details
2.12.2 Sichuan Hairong Pharmaceutical Major Business
2.12.3 Sichuan Hairong Pharmaceutical Palonosetron Product and Services
2.12.4 Sichuan Hairong Pharmaceutical Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Exela Pharma
2.13.1 Exela Pharma Details
2.13.2 Exela Pharma Major Business
2.13.3 Exela Pharma Palonosetron Product and Services
2.13.4 Exela Pharma Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Palonosetron Breakdown Data by Manufacturer
3.1 Global Palonosetron Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Palonosetron Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Palonosetron
3.4 Market Concentration Rate
3.4.1 Top 3 Palonosetron Manufacturer Market Share in 2021
3.4.2 Top 6 Palonosetron Manufacturer Market Share in 2021
3.5 Global Palonosetron Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Palonosetron Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Palonosetron Market Size by Region
4.1.1 Global Palonosetron Sales in Volume by Region (2017-2028)
4.1.2 Global Palonosetron Revenue by Region (2017-2028)
4.2 North America Palonosetron Revenue (2017-2028)
4.3 Europe Palonosetron Revenue (2017-2028)
4.4 Asia-Pacific Palonosetron Revenue (2017-2028)
4.5 South America Palonosetron Revenue (2017-2028)
4.6 Middle East and Africa Palonosetron Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Palonosetron Sales in Volume by Type (2017-2028)
5.2 Global Palonosetron Revenue by Type (2017-2028)
5.3 Global Palonosetron Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Palonosetron Sales in Volume by Application (2017-2028)
6.2 Global Palonosetron Revenue by Application (2017-2028)
6.3 Global Palonosetron Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Palonosetron Sales by Type (2017-2028)
7.2 North America Palonosetron Sales by Application (2017-2028)
7.3 North America Palonosetron Market Size by Country
7.3.1 North America Palonosetron Sales in Volume by Country (2017-2028)
7.3.2 North America Palonosetron Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Palonosetron Sales by Type (2017-2028)
8.2 Europe Palonosetron Sales by Application (2017-2028)
8.3 Europe Palonosetron Market Size by Country
8.3.1 Europe Palonosetron Sales in Volume by Country (2017-2028)
8.3.2 Europe Palonosetron Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Palonosetron Sales by Type (2017-2028)
9.2 Asia-Pacific Palonosetron Sales by Application (2017-2028)
9.3 Asia-Pacific Palonosetron Market Size by Region
9.3.1 Asia-Pacific Palonosetron Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Palonosetron Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Palonosetron Sales by Type (2017-2028)
10.2 South America Palonosetron Sales by Application (2017-2028)
10.3 South America Palonosetron Market Size by Country
10.3.1 South America Palonosetron Sales in Volume by Country (2017-2028)
10.3.2 South America Palonosetron Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Palonosetron Sales by Type (2017-2028)
11.2 Middle East & Africa Palonosetron Sales by Application (2017-2028)
11.3 Middle East & Africa Palonosetron Market Size by Country
11.3.1 Middle East & Africa Palonosetron Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Palonosetron Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Palonosetron and Key Manufacturers
12.2 Manufacturing Costs Percentage of Palonosetron
12.3 Palonosetron Production Process
12.4 Palonosetron Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Palonosetron Typical Distributors
13.3 Palonosetron Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Palonosetron Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Palonosetron Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Helsinn Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Helsinn Therapeutics Major Business
Table 5. Helsinn Therapeutics Palonosetron Product and Services
Table 6. Helsinn Therapeutics Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Palonosetron Product and Services
Table 10. Teva Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Dr. Reddys Laboratories Major Business
Table 13. Dr. Reddys Laboratories Palonosetron Product and Services
Table 14. Dr. Reddys Laboratories Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cipla Basic Information, Manufacturing Base and Competitors
Table 16. Cipla Major Business
Table 17. Cipla Palonosetron Product and Services
Table 18. Cipla Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Palonosetron Product and Services
Table 22. Pfizer Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sandoz Basic Information, Manufacturing Base and Competitors
Table 24. Sandoz Major Business
Table 25. Sandoz Palonosetron Product and Services
Table 26. Sandoz Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 28. Aurobindo Major Business
Table 29. Aurobindo Palonosetron Product and Services
Table 30. Aurobindo Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Sagent Pharmaceuticals Major Business
Table 33. Sagent Pharmaceuticals Palonosetron Product and Services
Table 34. Sagent Pharmaceuticals Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 36. Fresenius Kabi Major Business
Table 37. Fresenius Kabi Palonosetron Product and Services
Table 38. Fresenius Kabi Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Qilu Pharmaceutical Major Business
Table 41. Qilu Pharmaceutical Palonosetron Product and Services
Table 42. Qilu Pharmaceutical Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Jiangsu Aosaikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Jiangsu Aosaikang Pharmaceutical Major Business
Table 45. Jiangsu Aosaikang Pharmaceutical Palonosetron Product and Services
Table 46. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Sichuan Hairong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Sichuan Hairong Pharmaceutical Major Business
Table 49. Sichuan Hairong Pharmaceutical Palonosetron Product and Services
Table 50. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Exela Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Exela Pharma Major Business
Table 53. Exela Pharma Palonosetron Product and Services
Table 54. Exela Pharma Palonosetron Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Palonosetron Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Palonosetron Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Palonosetron, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Palonosetron Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Palonosetron Production Site of Key Manufacturer
Table 60. Palonosetron New Entrant and Capacity Expansion Plans
Table 61. Palonosetron Mergers & Acquisitions in the Past Five Years
Table 62. Global Palonosetron Sales by Region (2017-2022) & (K Units)
Table 63. Global Palonosetron Sales by Region (2023-2028) & (K Units)
Table 64. Global Palonosetron Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Palonosetron Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Palonosetron Sales by Type (2017-2022) & (K Units)
Table 67. Global Palonosetron Sales by Type (2023-2028) & (K Units)
Table 68. Global Palonosetron Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Palonosetron Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Palonosetron Price by Type (2017-2022) & (USD/Unit)
Table 71. Global Palonosetron Price by Type (2023-2028) & (USD/Unit)
Table 72. Global Palonosetron Sales by Application (2017-2022) & (K Units)
Table 73. Global Palonosetron Sales by Application (2023-2028) & (K Units)
Table 74. Global Palonosetron Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Palonosetron Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Palonosetron Price by Application (2017-2022) & (USD/Unit)
Table 77. Global Palonosetron Price by Application (2023-2028) & (USD/Unit)
Table 78. North America Palonosetron Sales by Country (2017-2022) & (K Units)
Table 79. North America Palonosetron Sales by Country (2023-2028) & (K Units)
Table 80. North America Palonosetron Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Palonosetron Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Palonosetron Sales by Type (2017-2022) & (K Units)
Table 83. North America Palonosetron Sales by Type (2023-2028) & (K Units)
Table 84. North America Palonosetron Sales by Application (2017-2022) & (K Units)
Table 85. North America Palonosetron Sales by Application (2023-2028) & (K Units)
Table 86. Europe Palonosetron Sales by Country (2017-2022) & (K Units)
Table 87. Europe Palonosetron Sales by Country (2023-2028) & (K Units)
Table 88. Europe Palonosetron Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Palonosetron Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Palonosetron Sales by Type (2017-2022) & (K Units)
Table 91. Europe Palonosetron Sales by Type (2023-2028) & (K Units)
Table 92. Europe Palonosetron Sales by Application (2017-2022) & (K Units)
Table 93. Europe Palonosetron Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Palonosetron Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Palonosetron Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Palonosetron Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Palonosetron Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Palonosetron Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Palonosetron Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Palonosetron Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Palonosetron Sales by Application (2023-2028) & (K Units)
Table 102. South America Palonosetron Sales by Country (2017-2022) & (K Units)
Table 103. South America Palonosetron Sales by Country (2023-2028) & (K Units)
Table 104. South America Palonosetron Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Palonosetron Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Palonosetron Sales by Type (2017-2022) & (K Units)
Table 107. South America Palonosetron Sales by Type (2023-2028) & (K Units)
Table 108. South America Palonosetron Sales by Application (2017-2022) & (K Units)
Table 109. South America Palonosetron Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Palonosetron Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Palonosetron Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Palonosetron Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Palonosetron Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Palonosetron Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Palonosetron Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Palonosetron Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Palonosetron Sales by Application (2023-2028) & (K Units)
Table 118. Palonosetron Raw Material
Table 119. Key Manufacturers of Palonosetron Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Palonosetron Typical Distributors
Table 123. Palonosetron Typical Customers
List of Figures
Figure 1. Palonosetron Picture
Figure 2. Global Palonosetron Revenue Market Share by Type in 2021
Figure 3. Injection 0.25 mg/5 mL
Figure 4. Injection 20 mcg/kg (max 1.5 mg)
Figure 5. Global Palonosetron Revenue Market Share by Application in 2021
Figure 6. Adults
Figure 7. Children
Figure 8. Global Palonosetron Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Palonosetron Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Palonosetron Sales (2017-2028) & (K Units)
Figure 11. Global Palonosetron Price (2017-2028) & (USD/Unit)
Figure 12. Global Palonosetron Production Capacity (2017-2028) & (K Units)
Figure 13. Global Palonosetron Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Palonosetron Market Drivers
Figure 15. Palonosetron Market Restraints
Figure 16. Palonosetron Market Trends
Figure 17. Global Palonosetron Sales Market Share by Manufacturer in 2021
Figure 18. Global Palonosetron Revenue Market Share by Manufacturer in 2021
Figure 19. Palonosetron Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Palonosetron Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Palonosetron Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Palonosetron Sales Market Share by Region (2017-2028)
Figure 23. Global Palonosetron Revenue Market Share by Region (2017-2028)
Figure 24. North America Palonosetron Revenue (2017-2028) & (USD Million)
Figure 25. Europe Palonosetron Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Palonosetron Revenue (2017-2028) & (USD Million)
Figure 27. South America Palonosetron Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Palonosetron Revenue (2017-2028) & (USD Million)
Figure 29. Global Palonosetron Sales Market Share by Type (2017-2028)
Figure 30. Global Palonosetron Revenue Market Share by Type (2017-2028)
Figure 31. Global Palonosetron Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Palonosetron Sales Market Share by Application (2017-2028)
Figure 33. Global Palonosetron Revenue Market Share by Application (2017-2028)
Figure 34. Global Palonosetron Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Palonosetron Sales Market Share by Type (2017-2028)
Figure 36. North America Palonosetron Sales Market Share by Application (2017-2028)
Figure 37. North America Palonosetron Sales Market Share by Country (2017-2028)
Figure 38. North America Palonosetron Revenue Market Share by Country (2017-2028)
Figure 39. United States Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Palonosetron Sales Market Share by Type (2017-2028)
Figure 43. Europe Palonosetron Sales Market Share by Application (2017-2028)
Figure 44. Europe Palonosetron Sales Market Share by Country (2017-2028)
Figure 45. Europe Palonosetron Revenue Market Share by Country (2017-2028)
Figure 46. Germany Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Palonosetron Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Palonosetron Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Palonosetron Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Palonosetron Revenue Market Share by Region (2017-2028)
Figure 55. China Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Palonosetron Sales Market Share by Type (2017-2028)
Figure 62. South America Palonosetron Sales Market Share by Application (2017-2028)
Figure 63. South America Palonosetron Sales Market Share by Country (2017-2028)
Figure 64. South America Palonosetron Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Palonosetron Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Palonosetron Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Palonosetron Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Palonosetron Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Palonosetron Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Palonosetron in 2021
Figure 76. Manufacturing Process Analysis of Palonosetron
Figure 77. Palonosetron Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用キシリトール市場2022年：市場規模予測（～2028年）
  • 世界の製薬業用ポンプ市場2022年：市場規模予測（～2028年）
  • 世界の医薬品スクリーニング機市場2022年：市場規模予測（～2028年）
  • 世界の経口製剤用医薬品賦形剤市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用魚油市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19510 )"世界のパロノセトロン市場2022年：市場規模予測（～2028年）" (英文：Global Palonosetron Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。